Clinical Trial Update: Fecal Microbiota Transplantation for Diabetes Mellitus Type II in Obese Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fecal microbiota transplantation for type 2 diabetes mellitus in obese patients; status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Diabetes Mellitus, Type 2, Obesity | Phase 2 | Status: UNKNOWN